Teva Pharma (TEVA)

Company Ticker Sector | Industry Quality PAR
Teva Pharma TEVA Healthcare | Drugs (Specialty & Generic) 39 4.9%
Current Price (01/18) $18.82
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 18,619.2
Sales Growth Forecast 0.9%
Net Profit Margin 12.8%
Projected Shares Outstanding 1,030.00
EPS - Five year Forecast $2.42
Average P/E Ratio 9.9
Projected Average Price $23.89
Price Appreciation (Annualized) 4.9%
Annual Dividend Yield 0.0%
Projected Annual Return 4.9%
Quality
Financial Strength 75 18.8
EPS Stability 38 9.6
Industry Sales Growth Rate 9.5% 1.2
Industry Net Profit Margin 17.0% 9.4
Calculated Quality Rating 39.0
Fool CAPS

Total Players

2300 Outperforms
80 Underperforms
 

All-Stars (372)

361 Outperforms (97%)
11 Underperforms
 
Fundamental Data Updated: 01/04/2019

MIPAR 9.3%  
Sweet Spot 14.3% - 19.3%  

Top In Drugs (Specialty & Generic)

Ticker Quality PAR
AGN 67 12.9%
PRGO 67 11.3%
DPLO 11 19.8%
PCRX 14 17.9%
ZTS 60 6.5%

Top In Healthcare

Ticker Quality PAR
ALGN 99 17.2%
JAZZ 97 17.5%
LMAT 85 17.0%
MD 84 17.0%
CVS 87 16.0%